Sort
25,944 grants matching “neurodegeneration”
Defining the Mechanisms by Which MS4A Genes Regulate TREM2 in Alzheimer Disease
$567,704Celeste Marie Karch · Washington University · R01 · FY2021 · AG
Defining the Mechanisms by Which MS4A Genes Regulate TREM2 in Alzheimer Disease
$567,704Celeste Marie Karch · Washington University · R01 · FY2022 · AG
Neuronal HDAC9, Synaptic Plasticity and Alzheimer's Disease
$567,615Xin-Yun Lu · Augusta University · R01 · FY2022 · AG
Neuronal HDAC9, Synaptic Plasticity and Alzheimer's Disease
$567,615Xin-Yun Lu · Augusta University · R01 · FY2024 · AG
Neuronal HDAC9, Synaptic Plasticity and Alzheimer's Disease
$567,615Xin-Yun Lu · Augusta University · R01 · FY2023 · AG
Antisense Oligonucleotides targeting APP to prevent neurodegeneration in models of Down Syndrome and Alzheimer's disease
$567,567William C Mobley · University Of California, San Diego · R01 · FY2020 · AG
Decoding global RNP topologies in splicing regulation
$567,494Zhipeng Lu · University Of Southern California · R01 · FY2023 · HG
Investigating the role of C9orf72 in autophagic and metabolic dysregulation in ALS/FTD
$567,481Jiou Wang · Johns Hopkins University · R01 · FY2023 · NS
Investigating the role of C9orf72 in autophagic and metabolic dysregulation in ALS/FTD
$567,481Jiou Wang · Johns Hopkins University · R01 · FY2022 · NS
Investigating the role of C9orf72 in autophagic and metabolic dysregulation in ALS/FTD
$567,481Jiou Wang · Johns Hopkins University · R01 · FY2021 · NS
Investigating the role of C9orf72 in autophagic and metabolic dysregulation in ALS/FTD
$567,481Jiou Wang · Johns Hopkins University · R01 · FY2020 · NS
Investigating the role of C9orf72 in autophagic and metabolic dysregulation in ALS/FTD
$567,481Jiou Wang · Johns Hopkins University · R01 · FY2024 · NS
The role of AIF3 in neurodegeneration of Alzheimer's disease
$567,251Yingfei Wang · Ut Southwestern Medical Center · R01 · FY2020 · AG
Neural substrates of opiate-HIV interactions.
$567,213Pietro P Sanna · Scripps Research Institute, The · R01 · FY2020 · DA
Mechanisms by which the ketone body β-hydroxybutyrate counteracts tau pathogenesis
$567,208Xu Chen · University Of California, San Diego · R01 · FY2025 · AG
Prediction of Psychosis in Alzheimer Disease
$567,204Robert A Sweet · University Of Pittsburgh At Pittsburgh · R01 · FY2013 · AG
Mechanisms of Corneal Neuro-Immune Crosstalk
$566,948Pedram Hamrah · Tufts Medical Center · R01 · FY2025 · EY
Discovery of Biomakers in Human Mitochondrial Disorders
$566,893Ronald Wayne Davis · Stanford University · R01 · FY2011 · EY
Mechanistic insights into the link between the A152T risk variant and tauopathy
$566,827Casey N Cook · Mayo Clinic Jacksonville · R01 · FY2020 · AG
Core A: Administrative Core
$566,792Henry L Paulson · University Of Michigan At Ann Arbor · P30 · FY2025 · AG
Aged T-cell-derived cytokines impact meningeal lymphatics and contribute to AD
$566,578Jonathan Kipnis · Washington University · R01 · FY2025 · AG
Maternal history of Alzheimer's predisposes children to amyloid beta-related hypo
$566,558Mony J. De Leon · New York University School Of Medicine · R01 · FY2011 · AG
Neurodevelopmental and neurodegenerative effects of environmental determinants: altering neural cellular populations impacting homeostatic functions and inflammatory response.
$566,285Nicholas Francis Fitz · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · AG
Molecular Mechanisms of Axonal Transport and Organelle Dynamics
$566,261Erika L Holzbaur · University Of Pennsylvania · R35 · FY2019 · GM
New Functions and Specificities of the Arg/N-Degron Pathway
$566,100Alexander J Varshavsky · California Institute Of Technology · R01 · FY2022 · GM